Context: Delirium is common in patients with advanced cancer, and antipsychotics are widely used for its management.
Objectives: We aimed to explore the association of the antipsychotic dose with survival of terminally ill cancer patients with delirium.
Methods: A secondary analysis of a multicenter prospective observational study was conducted.